Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions

Journal of Medical Virology

Volumn 81, Issue 9, 2009, Pages 1627-1634

  Cento, Valeria ^a   Ciccozzi, Massimo ^b   Ronga, Luigi ^a   Perno, Carlo Federico ^a,c   Ciotti, Marco ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

E6 E7 L1 genes; HPV16; HPV16 variants; Phylogenetic analysis

Indexed keywords

EPITOPE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; ITALY; MAJOR CLINICAL STUDY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; CLUSTER ANALYSIS; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENETIC VARIATION; HUMANS; ITALY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; SEQUENCE HOMOLOGY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 68949146965     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21552     Document Type: Article

References (33)

1. Alvarez-Salas LM, DiPaolo JA. 2007.Molecular approaches to cervical cancer therapy. Curr Drug Discov Technol 4:208-219. (Pubitemid 350171822)
2. Andersson S, Alemi M, Rylander E, Strand A, Larsson B, Sällström J, Wilander E. 2000. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer 83:307-310. (Pubitemid 30453568)
3. Baseman JG, Koustsky LA. 2005. The epidemiology of human papillomavirus infections. J Clin Virol 32:16-24.
4. Bishop B, Dasgupta J, Klein M, Garcea RL, Christensen ND, Zhao R, Chen XS. 2007. Crystal structures of four types of human papillomavirus L1 capsid proteins: Understanding the specificity of neutralizing monoclonal antibodies. J Biol Chem 282:31803-31811. (Pubitemid 350044858)
5. Brady CS, Duggan-Keen MF, Davidson JA, Varley JM, Stern PL. 1999. Human papillomavirus type 16 E6 variants in cervical carcinoma: Relationship to host genetic factors and clinical parameters. J Gen Virol 80:3233-3240.
6. Ciotti M, Giuliani L, Ambrogi V, Ronci C, Benedetto A, Mineo TC, Syrjanen K, Favalli C. 2006a. Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep 16:183-189.
7. Ciotti M, Coletti A, Giuliani L, Cappiello G, Syrjanen K, Favalli C. 2006b. The p53 codon 72 arg/arg homozygous women in Central Italy are at increased risk for HPV infections. Anticancer Res 26:3745-3748. (Pubitemid 44701453)
8. Crook T, Fisher C, Vousden KH. 1991. Modulation of immortalizing properties of human papillomavirus type 16E7 by p53 expression. J Virol 65:505-510.
9. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
10. Dyson N, Howley PM, Munger K, Harlow E. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937. (Pubitemid 19066153)
11. Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Young LS. 1995. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1:464-470.
12. Giroglou T, Sapp M, Lane C, Fligge C, Christensen ND, Streeck RE, Rose RC. 2001. Immunological analyses of human papillomavirus capsids. Vaccine 19:1783-1793. (Pubitemid 32175741)
13. Hall TA. 1999. Bioedit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98 NT. Nucl Acids Symp Ser 41:95-98.
14. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. 2001. Human papillomavirus type 16 variants and risk of cervical cancer- J Natl. Cancer Inst 93:315-318.
15. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 29:1765-1772.
16. Munger K. 2002. The role of human papillomaviruses in human cancers. Front Biosci 7:d641-d649.
17. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsangue X, Shah KV, Snijders PJF, Meijer CJLM. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527. (Pubitemid 36159887)
18. Munoz N, Castellsague X, deGonzalez AB, Gissmann L. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24S3:S1-S10.
19. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M. 1999. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelialneoplasiaandcervical cancer. Int J Cancer 82:203-207. (Pubitemid 29293778)
20. Ortiz M, Torres M,Muñoz L, Fernández-García E, Canals J, Cabornero AI, Aguilar E, Ballesteros J, Del Amo J, García-Sáiz A. 2006. Oncogenichumanpapillomavirus (HPV) type distribution andHPV typ16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 44:1428-1434.
21. Pande S, Jain N,PrustyBK,Bhambhani S,GuptaS,SharmaR, Batra S, Das BC. 2008. Human papillomavirus type 16 variant analysis of E6,E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol 46: 1060-1066.
22. Phelps WC,MungerK, Yee CL, Barnes JA,HowleyPM.1992. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol 66:2418-2427.
23. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG. 1985. Human papillomavirus type 16 DNA sequence. Virology 145: 181-185. (Pubitemid 15234421)
24. Swofford D, Sullivan J. 2003. Phylogeny Inference based on parsimony and other methods with PAUP*. In: Salemi M, Vandamme AM, editors. The phylogenetic handbook-A practical approach to DNA and protein phylogeny. New York:Cambridge University Press. pp. 160-206.
25. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM. 2004. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74:117-126. (Pubitemid 38988868)
26. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. 2000. Molecular variants ofhumanpapillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968. (Pubitemid 32000643)
27. Wise-Draper TM, Wells SI. 2008. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 13:1003-1017.
28. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802. (Pubitemid 27242281)
29. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69: 7743-7753.
30. Yamada T, Manos MM, Peto J, Greer CE, MunozN, Bosch FX, Wheeler CM. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol 71:2463-2472. (Pubitemid 27078630)
31. Zehbe I,VoglinoG,DeliusH,WilanderE, TommasinoM. 1998a. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441-1442.
32. Zehbe I, Wilander E, Delius H, Tommasino M. 1998b. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833. (Pubitemid 28099499)
33. Zur Hausen H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.